NGAL is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistance

10.3390/cancers10070228

Saved in:
Bibliographic Details
Main Authors: Monisha J., Roy N.K., Padmavathi G., Banik K., Bordoloi D., Khwairakpam A.D., Arfuso F., Chinnathambi A., Alahmadi T.A., Alharbi S.A., Sethi G., Kumar A.P., Kunnumakkara A.B.
Other Authors: DEPT OF PHARMACOLOGY
Format: Article
Published: MDPI AG 2019
Subjects:
Online Access:http://scholarbank.nus.edu.sg/handle/10635/152462
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-152462
record_format dspace
spelling sg-nus-scholar.10635-1524622023-09-06T08:32:00Z NGAL is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistance Monisha J. Roy N.K. Padmavathi G. Banik K. Bordoloi D. Khwairakpam A.D. Arfuso F. Chinnathambi A. Alahmadi T.A. Alharbi S.A. Sethi G. Kumar A.P. Kunnumakkara A.B. DEPT OF PHARMACOLOGY CANCER SCIENCE INSTITUTE OF SINGAPORE Drug resistance; mTOR pathway; Oral cancer; Secreted glycoprotein 10.3390/cancers10070228 Cancers 10 7 228 2019-03-20T03:46:15Z 2019-03-20T03:46:15Z 2018 Article Monisha J., Roy N.K., Padmavathi G., Banik K., Bordoloi D., Khwairakpam A.D., Arfuso F., Chinnathambi A., Alahmadi T.A., Alharbi S.A., Sethi G., Kumar A.P., Kunnumakkara A.B. (2018). NGAL is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistance. Cancers 10 (7) : 228. ScholarBank@NUS Repository. https://doi.org/10.3390/cancers10070228 20726694 http://scholarbank.nus.edu.sg/handle/10635/152462 MDPI AG Scopus
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic Drug resistance; mTOR pathway; Oral cancer; Secreted glycoprotein
spellingShingle Drug resistance; mTOR pathway; Oral cancer; Secreted glycoprotein
Monisha J.
Roy N.K.
Padmavathi G.
Banik K.
Bordoloi D.
Khwairakpam A.D.
Arfuso F.
Chinnathambi A.
Alahmadi T.A.
Alharbi S.A.
Sethi G.
Kumar A.P.
Kunnumakkara A.B.
NGAL is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistance
description 10.3390/cancers10070228
author2 DEPT OF PHARMACOLOGY
author_facet DEPT OF PHARMACOLOGY
Monisha J.
Roy N.K.
Padmavathi G.
Banik K.
Bordoloi D.
Khwairakpam A.D.
Arfuso F.
Chinnathambi A.
Alahmadi T.A.
Alharbi S.A.
Sethi G.
Kumar A.P.
Kunnumakkara A.B.
format Article
author Monisha J.
Roy N.K.
Padmavathi G.
Banik K.
Bordoloi D.
Khwairakpam A.D.
Arfuso F.
Chinnathambi A.
Alahmadi T.A.
Alharbi S.A.
Sethi G.
Kumar A.P.
Kunnumakkara A.B.
author_sort Monisha J.
title NGAL is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistance
title_short NGAL is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistance
title_full NGAL is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistance
title_fullStr NGAL is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistance
title_full_unstemmed NGAL is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistance
title_sort ngal is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistance
publisher MDPI AG
publishDate 2019
url http://scholarbank.nus.edu.sg/handle/10635/152462
_version_ 1778169014461136896